ResearcherDalian Medical UniversityActive in the last 2 years

Xiaohong H. Shu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0299-1963; OpenAlex author ID A5005110349. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells" [P… Last author DOI 10.1016/j.phymed.2024.156301 ↗
Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells. Last author DOI 10.1016/j.phymed.2021.153711 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaodong Ma · 2 shared papers, 2021–2025 · strength 0.32
- Paper Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabi… DOI 10.1016/j.phymed.2024.156301 ↗
- Paper Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant … DOI 10.1016/j.phymed.2021.153711 ↗
Peng Chu · 2 shared papers, 2021–2025 · strength 0.32
- Paper Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabi… DOI 10.1016/j.phymed.2024.156301 ↗
- Paper Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant … DOI 10.1016/j.phymed.2021.153711 ↗
Jinyong Peng · 2 shared papers, 2021–2025 · strength 0.32
- Paper Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabi… DOI 10.1016/j.phymed.2024.156301 ↗
- Paper Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant … DOI 10.1016/j.phymed.2021.153711 ↗
Abdullah Shopit · 2 shared papers, 2021–2025 · strength 0.32
- Paper Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabi… DOI 10.1016/j.phymed.2024.156301 ↗
- Paper Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant … DOI 10.1016/j.phymed.2021.153711 ↗
Zeyao Tang · 2 shared papers, 2021–2025 · strength 0.32
- Paper Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabi… DOI 10.1016/j.phymed.2024.156301 ↗
- Paper Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant … DOI 10.1016/j.phymed.2021.153711 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.